VBLT — VASCULAR BIOGENICS LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
VBLT (VASCULAR BIOGENICS LTD) is tracked on HoldingsHub across five years of quarterly 13F filings. 28 funds have reported positions historically, with the sum of their latest reported stakes valued at $3.02M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of VASCULAR BIOGENICS LTD (VBLT) include ARK Invest, Northern Trust Corp, Squarepoint Ops LLC, ranked by reported 13F value among the 28 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2023 | 21 | 968.35K | $236.76K | -28.4% |
| Q2 2023 | 4 | 408.43K | $93.94K | -14.1% |
| Q1 2023 | 5 | 514.33K | $86.16K | -19.4% |
| Q4 2022 | 8 | 1.03M | $123.42K | -35.9% |
| Q3 2022 | 8 | 1.61M | $250.00K | -25.3% |
| Q2 2022 | 7 | 1.12M | $1.80M | +22.6% |
| Q1 2022 | 7 | 896.12K | $1.51M | -4.9% |
| Q4 2021 | 8 | 2.27M | $4.48M | -9.4% |
Over the 8 quarters shown, institutional share counts decreased 57% in aggregate (Q4 2021 → Q3 2023); the largest single-quarter swing was Q4 2022 (-35.9%).
Top Institutional Holders (Q3 2023) — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 227.21K | $55.44K | 0.00% | New | |
| 211.11K | $51.59K | 0.00% | Reduce | |
| 155.36K | $37.91K | 0.00% | New | |
| 97.18K | $23.71K | 0.00% | New | |
| 52.57K | $12.85K | 0.00% | New | |
| 40.32K | $9.84K | 0.00% | Hold | |
| 39.00K | $9.53K | 0.00% | New | |
| 32.90K | $8.04K | 0.00% | Hold | |
| 21.90K | $5.35K | 0.00% | New | |
| 20.57K | $5.03K | 0.00% | New | |
| 16.00K | $3.91K | 0.01% | New | |
| 15.00K | $3.67K | 0.00% | New | |
| 11.00K | $3.00K | 0.00% | New | |
| 11.73K | $2.86K | 0.00% | New | |
| 8.19K | $2.00K | 0.00% | Hold | |
| 4.00K | $976 | 0.00% | New | |
| 1.70K | $415 | 0.00% | New | |
| 1.50K | $366 | 0.00% | New | |
| 937 | $229 | 0.00% | New | |
| 100 | $24 | 0.00% | New | |
| 53 | $13 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2023 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 327.01K | $75.21K | 0.00% | Reduce | |
| 40.32K | $9.27K | 0.00% | Hold | |
| 32.90K | $7.57K | 0.00% | Add | |
| 8.19K | $1.88K | 0.00% | Hold |
Q1 2023 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 409.01K | $68.51K | 0.00% | Reduce | |
| 40.32K | $6.76K | 0.00% | Hold | |
| 39.00K | $6.53K | 0.00% | Hold | |
| 17.80K | $2.98K | 0.00% | Reduce | |
| 8.19K | $1.37K | 0.00% | Hold |
Q4 2022 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 429.61K | $51.55K | 0.00% | Add | |
| 264.50K | $32.00K | 0.00% | Reduce | |
| 128.32K | $15.40K | 0.00% | Reduce | |
| 120.60K | $14.47K | 0.00% | Reduce | |
| 39.00K | $4.68K | 0.00% | Hold | |
| 40.32K | $4.00K | 0.00% | Hold | |
| 8.19K | $983 | 0.00% | Hold | |
| 2.78K | $334 | 0.00% | Reduce |
Q3 2022 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 425.99K | $66.00K | 0.00% | New | |
| 377.91K | $59.00K | 0.00% | Reduce | |
| 332.60K | $52.00K | 0.00% | New | |
| 321.88K | $50.00K | 0.00% | Reduce | |
| 64.92K | $10.00K | 0.00% | New | |
| 39.00K | $6.00K | 0.00% | Hold | |
| 40.32K | $6.00K | 0.00% | Hold | |
| 8.19K | $1.00K | 0.00% | Reduce |
Q2 2022 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 600.01K | $966.00K | 0.00% | Reduce | |
| 363.13K | $584.00K | 0.00% | Add | |
| 44.94K | $72.00K | 0.00% | Hold | |
| 40.32K | $64.00K | 0.00% | Hold | |
| 39.00K | $63.00K | 0.00% | Hold | |
| 19.21K | $31.00K | 0.00% | New | |
| 11.13K | $18.00K | 0.00% | Add |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Squarepoint Ops LLC | 227.21K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 211.11K | 327.01K | 409.01K | 429.61K | 377.91K | 600.01K | 615.61K | 643.41K | 676.21K | — | — | — | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 155.36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GROUP ONE TRADING LLC | 97.18K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | 52.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 40.32K | 40.32K | 40.32K | 40.32K | 40.32K | 40.32K | 40.32K | 40.32K | 40.32K | — | — | — | — | — | — | — | — | — | — |
| CATALYST FINANCIAL PARTNERS LLC | 39.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Two Sigma Investments | 32.90K | 32.90K | 17.80K | 120.60K | 425.99K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 21.90K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HBK Sorce Advisory LLC | 20.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Spectrum Planning & Advisory Services Inc. | 16.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TWO SIGMA ADVISERS, LP | 15.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Harel Insurance Investments & Financial Services Ltd. | 11.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| XTX Topco Ltd | 11.73K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | 8.19K | 8.19K | 8.19K | 8.19K | 8.19K | 11.13K | 10.72K | 8.19K | 8.19K | — | — | — | — | — | — | — | — | — | — |
| Federation des caisses Desjardins du Quebec | 4.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NewEdge Advisors, LLC | 1.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 937 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 100 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
FAQ
Which funds hold VBLT?
28 funds have reported positions in VBLT across five years of 13F filings; the sum of their latest reported stakes is $3.02M.
Who are the top institutional holders of VBLT?
The largest 13F holders are ARK Invest, Northern Trust Corp, Squarepoint Ops LLC, Morgan Stanley, SUSQUEHANNA INTERNATIONAL GROUP, LLP; the top 25 are ranked at the top of this page.
Who are the major shareholders of VASCULAR BIOGENICS LTD?
The major shareholders of VASCULAR BIOGENICS LTD (VBLT) by reported 13F value are ARK Invest, Northern Trust Corp, Squarepoint Ops LLC, Morgan Stanley, SUSQUEHANNA INTERNATIONAL GROUP, LLP, among 28 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.